CTRI/2023/07/055182Not yet recruitingPhase 1
Efficacy of calcium gluconate in prevention of uterine atony during lower segmental cesarean section delivery: A randomized controlled trial
AIIMS New Delhi0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1)Pregnant female patients (18 to 45 years of age)
- •2)ASA physical class II or III
- •3)Emergency or elective LSCS with risk factors of PPH
- •4)Patients who have atleast two of the following established risk factors for uterine atony: intrapartum Cesarean delivery, failed operative vaginal delivery with forceps or vacuum, magnesium infusion, Chorioamnionitis, multiple gestation, Polyhydramnios, preterm delivery <37 weeks, prior history of postpartum hemorrhage, labor induction or augmentation with oxytocin, advanced maternal age, obesity with body mass index >40.
Exclusion Criteria
- •1)Patient refusal to participate in the study
- •2)Maternal history of cardiac disease, arrhythmias, CAD
- •3)History of renal dysfunction with serum creatinine >1.0 mg/dL
- •4)Patients with placenta accreta
- •5)Treatment with digoxin within the last 2 weeks for a maternal or fetal indication
- •6)Treatment with a calcium channel blocker within 24 hours
- •7)General anaesthesia
Investigators
Similar Trials
Completed
Not Applicable
Effects of calcium in the prevention of ovarian hyperstimulation syndrome in patients undergoing IVF/ICSIovarian hyperstimulation.Hyperstimulation of ovariesIRCT2016071428930N1Vice Chancellor Of Research, Mashhad University of Medical Sciences186
Not yet recruiting
Not Applicable
Is prophylactic Potassium Citrate effective in preventing bladder stones after acute spinal cord injury?GU stones in SCIbladder stonesNeurological - Other neurological disordersPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationRenal and Urogenital - Other renal and urogenital disordersspinal cord injuryACTRN12616000949482Canterbury District Health Board (CDHB)240
Active, not recruiting
Not Applicable
Role of the Glutatione reduced in the prevention of neuro-toxicity from Oxaliplatino.Patients with neoplasia malignant.MedDRA version: 14.1Level: HLTClassification code 10010023Term: Colorectal neoplasms malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-007059-14-ITAZIENDA DI RILIEVO NAZIONALE E DI ALTA SPECIALIZZAZIONE OSPEDALE CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI
Completed
Not Applicable
The effect of Glutamine Oral gel onprevention of chemotherapy-induced mucositisOral mucositis.Oral mucositis (ulcerative)IRCT201411153106N19Pharmaceutical science branch of Islamic Azad University50
Completed
Phase 3
Evaluation of calcium gluconate on reduction of abdominal pain caused by lead toxicityIRCT20171009036661N2Kerman University of Medical Sciences50